| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|
| 40.902.292 $ | 60,71 | 367.337 | |||||
| Gilead Sciences, Inc. | Gilead Sciences, Inc. | EC | 375558103 | Long | 4.979.153 $ | 7,39 | 37.039 |
| Vertex Pharmaceuticals Inc. | Vertex Pharmaceuticals Inc. | EC | 92532F100 | Long | 4.969.484 $ | 7,38 | 11.104 |
| Amgen Inc. | Amgen Inc. | EC | 031162100 | Long | 4.786.796 $ | 7,10 | 14.213 |
| Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. | EC | 75886F107 | Long | 3.424.325 $ | 5,08 | 5.570 |
| Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals, Inc. | EC | 02043Q107 | Long | 2.147.078 $ | 3,19 | 7.110 |
| Revolution Medicines, Inc. | Revolution Medicines, Inc. | EC | 76155X100 | Long | 1.673.068 $ | 2,48 | 10.624 |
| Biogen Inc. | Biogen Inc. | EC | 09062X103 | Long | 1.542.128 $ | 2,29 | 7.868 |
| Illumina, Inc. | Illumina, Inc. | EC | 452327109 | Long | 1.335.783 $ | 1,98 | 8.197 |
| United Therapeutics Corp. | United Therapeutics Corp. | EC | 91307C102 | Long | 1.308.527 $ | 1,94 | 2.350 |
| Royalty Pharma PLC | Royalty Pharma PLC, Class A | EC | G7709Q104 | Long | 1.280.696 $ | 1,90 | 22.968 |
| argenx SE | argenx SE, ADR | EC | 04016X101 | Long | 1.271.541 $ | 1,89 | 1.521 |
| Insmed Inc. | Insmed Inc. | EC | 457669307 | Long | 1.235.452 $ | 1,83 | 11.556 |
| Roivant Sciences Ltd. | Roivant Sciences Ltd. | EC | G76279101 | Long | 1.150.716 $ | 1,71 | 38.370 |
| Incyte Corp. | Incyte Corp. | EC | 45337C102 | Long | 1.032.119 $ | 1,53 | 10.669 |
| Viatris Inc. | Viatris Inc. | EC | 92556V106 | Long | 1.003.697 $ | 1,49 | 61.728 |
| Moderna, Inc. | Moderna, Inc. | EC | 60770K107 | Long | 999.154 $ | 1,48 | 21.173 |
| Guardant Health, Inc. | Guardant Health, Inc. | EC | 40131M109 | Long | 911.980 $ | 1,35 | 7.032 |
| Neurocrine Biosciences, Inc. | Neurocrine Biosciences, Inc. | EC | 64125C109 | Long | 851.812 $ | 1,26 | 5.381 |
| Jazz Pharmaceuticals PLC | Jazz Pharmaceuticals PLC | EC | G50871105 | Long | 780.417 $ | 1,16 | 3.300 |
| Ascendis Pharma A/S | Ascendis Pharma A/S | EC | K08588103 | Long | 739.787 $ | 1,10 | 3.301 |
| Summit Therapeutics Inc. | Summit Therapeutics Inc. | EC | 86627T108 | Long | 729.120 $ | 1,08 | 41.569 |
| Exelixis, Inc. | Exelixis, Inc. | EC | 30161Q104 | Long | 702.833 $ | 1,04 | 13.923 |
| BridgeBio Pharma, Inc. | BridgeBio Pharma, Inc. | EC | 10806X102 | Long | 688.640 $ | 1,02 | 10.393 |
| Medpace Holdings, Inc. | Medpace Holdings, Inc. | EC | 58506Q109 | Long | 680.501 $ | 1,01 | 1.522 |
| Ionis Pharmaceuticals, Inc. | Ionis Pharmaceuticals, Inc. | EC | 462222100 | Long | 677.484 $ | 1,01 | 8.856 |
| 40.902.292 $ | 60,71 | 367.337 |